Trial Information

Summary: High Dose Chemotherapy and Combination anti-HIV Therapy for HIV-Associated Hodgkin's and Non-Hodgkin's Lymphoma

The purpose of this research study is to determine whether peripheral blood progenitor cells (immature cells that can become blood cells) can be collected from patients with HIV infection who are being treated with combination anti-HIV therapy. These cells will be given back to research participants after high dose chemotherapy for non-Hodgkin's lymphoma (NHL) or Hodgkin's Disease (HD). Additional purposes are to evaluate the side effects of this treatment and estimate the disease-free and overall survival.

Patient Inclusion/Exclusion Criteria:

- Between 10 and 60 years of age - Diagnosed with HIV infection and non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) - Must have had prior chemotherapy
- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 2, 2008 at 2:50:44 PM